Back

ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC Registry of pregnancy and cardiac disease (ROPAC)

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pregnancy and cardiovascular disease Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Jolien W Roos-Hesselink

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Pregnancy and inherited aortopathies: insights from specialized care
Doctor E. Sola Garcia (Jaen, ES)
Abstract Slides Video
Presentation thumbnail
Pregnancy and inherited cardiomyopathies: insights from specialized care
Doctor E. Sola Garcia (Jaen, ES)
Abstract Slides Video
Presentation thumbnail
Characterization of left atrial function during cardiac (reverse) remodeling induced by pregnancy
Miss A. Ferreira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Worse ischemic symptoms and cardiac function in women with suspected ischemia with no obstructive coronary artery disease and adverse pregnancy outcomes history
Assistant Professor O. Quesada (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Unlocking equity: assessing for gaps in cardiovascular guidelines for pregnant women
Doctor E. Ekpo (San Diego, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pregnancy and cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Diuretic use in pregnancy: data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC)
thumbnail
Congress Presentation
Effects on reduction of morbidity and mortality in ACHD population of childbearing age as a result of ESC Guidelines
thumbnail
Congress Presentation
Maternal and fetal outcomes of various lipid-lowering treatment regimens during pregnancy: insights from the czech national registry 2012-2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources